liver cancer
Conditions
Interventions
The SNMC group 15 cases From the day of hospitalization for the operation the first and the third day and week 1, 2, 4 and 8. (Blood collection at the 8th week is not obligatory and lack of data of
Sponsors
HYOGO COLLEGE OF MEDICINE Internal medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients of primary liver cancer due to chronic hepatitis C with Child Pugh grade A and B.
Exclusion criteria
Exclusion criteria: 1) Basal disease of the cancer of liver is the following: Viral hepatitis other than C type, alcoholic hepatitis, drug induced hepatic injury, autoimmune hepatitis, primary biliary cirrhosis, Hemocromatois and congenital metabolic liver diseases such as Wilson disease. 2) Patients of untreated esophageal piles of F2 or patients of esophageal piles with positive RC sign. 3) Pregnant women and those with possibility of pregnancy. 4) Children and women lactating. 5) Stronger Neo-Minophagen C contra- indicated patients. 6) Other patients judged by the responsible investigators adequate to exclude.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Biochemical test: AST, ALT, gamma-GTP, TB, DB, PT, and Pre-Alb Liver reproduction promotion marker: HGF, IL-6, and TNF-alpha | — |
Secondary
| Measure | Time frame |
|---|---|
| Tumor marker: AFP and PIVKA HCV-RNA test: A quantitative test is done. | — |
Countries
Japan
Contacts
Public ContactShuhei NISHIGUCHI
HYOGO COLLEGE OF MEDICINE Internal medicine
Outcome results
None listed